5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients.
5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients.
T. Gleason,M. Reardon,20 Authors,CoreValve U.S. Pivotal High Risk Trial Clinical Investigators
2018 · DOI: 10.1016/j.jacc.2018.08.2146
Journal of the American College of Cardiology · 323 Citations
TLDR
This study shows similar mid-term survival and stroke rates in high-risk patients following TAVR or SAVR, and suggests that valve reinterventions were uncommon.